脱水药
- 网络Dehydrants;dehydrant agents
-
结果:有20例药源性肾功能损害(占19。6%),可疑药物包括脱水药、抗生素、血管紧张素转换酶抑制剂等22种。
RESULTS : Of the102 cases , 20 patients ( 19.6 % ) suffered from drug-induced renal injury induced by22 suspected drugs including dehydrants , antibiotics and ACEI et al .
-
结果:本组病历中大都采用脱水药、溶栓药、抗血小板聚集,改善脑循环,改善脑代谢及支持疗法为主的综合性疗法。
Result : The investigated cases were almost used dehydrants , thrombolytic drugs , anti-platelet-agglutination to improve cerebral circulation and cerebral metabolism , and the combined therapy mainly on supporting treatment .
-
引起ICH患者血粘度增高的主要因素有高血压病史、糖尿病史、冠心病史、高脂血症、出血量、出血部位、脱水药及入院后进食情况。
The main risk factors inducing hyperviscosity are hypertensive disease , diabetes , coronary artery disease , hyperlipemia , hematoma volume , bleeding part , diet state and dehydration drugs .
-
术后应用神经恢复药及脱水药。
After operation , the nerve recovery and dehydration medicine were applied .
-
引起肺水肿的药物种类以抗精神病药、利尿脱水药较多。
The pulmonary edemas were predominantly caused by anti-psychotic drug and dehydration drugs .
-
在医药行业,甘露醇可作为脱水药和利尿药。
In pharmaceutical industry , mannitol was used as diuretics and dehydrating agent .
-
复方甘油注射液系新脱水药。
The injection solution of compound glycerin is a new type of dehydrated medicines .
-
伤后24小时内出现高钠血症主要为原发性下丘脑损伤所致,24小时后出现者也与使用脱水药有关。
The occurrence of hypernatremia within 24 hours after injury was mainly induced by primary hypothalamus injury which was also related to the use of dehydrant .
-
结果:本组病例大都采用以脱水药、溶栓药、抗血小板改善脑循环、营养脑细胞、支持疗法为主的中西医结合疗法。
The results showed that the treatment mainly covered dehydration , thrombolysis , improvement of cerebral circulation , nutritional and supporting therapies , which combined the traditional Chinese and Western medicine .
-
脑水肿不仅是许多神经系统疾病共同的病理现象,还是导致这些疾病后来致命性神经损伤的关键因素,然而针对脑水肿的治疗,应用传统脱水药并不能明显改善预后和降低死亡率。
Cerebral edema is common pathological phenomenon of many neurological diseases , and a key factor of the deadly nerve injury cause these diseases later , for the treatment of cerebral edema , however , the application of traditional dehydrated drugs and can not significantly improve the prognosis and mortality .